New Zealand markets close in 2 hours 42 minutes

Qingdao Vland Biotech INC. (603739.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.85-0.06 (-0.46%)
As of 10:03AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.27B
Enterprise value 3.49B
Trailing P/E 39.12
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.57
Price/book (mrq)1.90
Enterprise value/revenue 2.79
Enterprise value/EBITDA 23.52

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-0.23%
S&P500 52-week change 324.96%
52-week high 322.35
52-week low 37.70
50-day moving average 314.18
200-day moving average 313.20

Share statistics

Avg vol (3-month) 315.64M
Avg vol (10-day) 312.61M
Shares outstanding 5253.03M
Implied shares outstanding 6253.03M
Float 883.91M
% held by insiders 167.97%
% held by institutions 10.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.1
Forward annual dividend yield 40.77%
Trailing annual dividend rate 30.10
Trailing annual dividend yield 30.77%
5-year average dividend yield 40.86
Payout ratio 430.30%
Dividend date 3N/A
Ex-dividend date 430 May 2024
Last split factor 21.4:1
Last split date 325 May 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.61%
Operating margin (ttm)7.85%

Management effectiveness

Return on assets (ttm)2.49%
Return on equity (ttm)5.99%

Income statement

Revenue (ttm)1.25B
Revenue per share (ttm)5.02
Quarterly revenue growth (yoy)23.30%
Gross profit (ttm)N/A
EBITDA 187.89M
Net income avi to common (ttm)82.87M
Diluted EPS (ttm)0.33
Quarterly earnings growth (yoy)20.50%

Balance sheet

Total cash (mrq)508.82M
Total cash per share (mrq)2.01
Total debt (mrq)735.56M
Total debt/equity (mrq)39.96%
Current ratio (mrq)1.04
Book value per share (mrq)6.81

Cash flow statement

Operating cash flow (ttm)126.66M
Levered free cash flow (ttm)61.04M